CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium
- PMID: 7544810
- PMCID: PMC185786
- DOI: 10.1172/JCI118199
CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium
Abstract
Human nasal polyps from non-CF and delta F 508 homozygous CF patients were used to compare the expression of CFTR and markers epithelial differentiation, such as cytokeratins (CK) and desmoplakins (DP), at the transcriptional and translational levels. mRNA expression was assessed by semiquantitative RT/PCR kinetic assays while the expression and distribution of proteins were evaluated by immunofluorescence analysis. In parallel, for each nasal tissue specimen, the importance of surface epithelium remodeling and inflammation was estimated after histological observations. Our results show that the steady-state levels of CFTR, CK13, CK18, CK18, CK14, or DP 1 mRNA transcripts in delta F 508 CF nasal polyps were not significantly different from those of non-CF tissues. A variability in the CFTR mRNA transcript level and in the pattern of CFTR immunolabeling has been observed between the different tissue samples. However, no relationship was found between the level of CFTR mRNA transcripts and the CFTR protein expression and distribution, either in the non-CF or in the CF group. The histological observations of non-CF and CF nasal polyp tissue indicated that the huge variations in the expression and distribution of the CFTR protein were associated with the variations in the degree of surface epithelium remodeling and inflammation in the lamina propria. A surface epithelium, showing a slight basal cell hyperplasia phenotype associated with diffuse inflammation, was mainly characterized by a CFTR protein distribution at the apex of ciliated cells in both non-CF and CF specimens. In contrast, in a remodeled surface epithelium associated with severe inflammation, CFTR protein presented either a diffuse distribution in the cytoplasm of ciliated cells, or was absent. These results suggest that abnormal expression and distribution of the CFTR protein of CF airways is not only caused by CFTR mutations. Airway surface epithelium remodeling and inflammation could play a critical role in the posttranscriptional and/or the posttranslational regulation of the CFTR protein expression in non-CF and CF airways.
Similar articles
-
Decreased expression of the CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients.Lab Invest. 1995 Feb;72(2):191-200. Lab Invest. 1995. PMID: 7531792
-
Nonsense mutation R1162X of the cystic fibrosis transmembrane conductance regulator gene does not reduce messenger RNA expression in nasal epithelial tissue.J Clin Invest. 1993 Dec;92(6):2683-7. doi: 10.1172/JCI116885. J Clin Invest. 1993. PMID: 7504691 Free PMC article.
-
Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.J Clin Invest. 1991 Dec;88(6):1880-5. doi: 10.1172/JCI115510. J Clin Invest. 1991. PMID: 1721624 Free PMC article.
-
Dysfunction of CFTR bearing the delta F508 mutation.J Cell Sci Suppl. 1993;17:235-9. J Cell Sci Suppl. 1993. PMID: 7511616 Review.
-
Analysis of nasal potential in murine cystic fibrosis models.Int J Biochem Cell Biol. 2016 Nov;80:87-97. doi: 10.1016/j.biocel.2016.10.001. Epub 2016 Oct 4. Int J Biochem Cell Biol. 2016. PMID: 27717840 Review.
Cited by
-
Tissue and cellular expression patterns of porcine CFTR: similarities to and differences from human CFTR.J Histochem Cytochem. 2010 Sep;58(9):785-97. doi: 10.1369/jhc.2010.955377. Epub 2010 May 24. J Histochem Cytochem. 2010. PMID: 20498480 Free PMC article.
-
Pitfalls in the immunohistochemical localization of the cystic fibrosis transmembrane conductance regulator in paraffin embedded sweat glands.Histochem J. 2000 Oct;32(10):617-24. doi: 10.1023/a:1026744707198. Histochem J. 2000. PMID: 11202158
-
DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis.J Clin Invest. 1999 May 15;103(10):1379-89. doi: 10.1172/JCI5731. J Clin Invest. 1999. PMID: 10330420 Free PMC article.
-
Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier.PLoS Genet. 2010 Oct 7;6(10):e1001153. doi: 10.1371/journal.pgen.1001153. PLoS Genet. 2010. PMID: 20949073 Free PMC article.
-
Nano-scientific Application of Atomic Force Microscopy in Pathology: from Molecules to Tissues.Int J Med Sci. 2020 Mar 15;17(7):844-858. doi: 10.7150/ijms.41805. eCollection 2020. Int J Med Sci. 2020. PMID: 32308537 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous